-
RE: Active substance registration
Registration of CAR Tell product in IRIS,
Dear all,
If I want to use an individualised ATMP (without approval in the EU), a CAR T Cell product, in a clinical trial, do I have to register the product individually for each patient or is the CAR considered an active substance?
Thank you for your answer in advance
Kind Regards
Rita
You’re offline. This is a read only version of the page.
